Atlas Trials

Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study

Clinical trial NCT04917731 · UNKNOWN

Trial details

NCT number
NCT04917731
Sponsor
Massachusetts General Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Cold Intolerance
Start date
2021-06-02
Primary completion
2023-06-02
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.